HCV Viral Hepatitis, Blood Sugar Level and Systolic Blood Pressure in Egypt

NCT03839979 | Completed DMC FDA Device

• 1 other identifier: One million healthy citizen 18
• Study Type: observational
• Target: 71,975
• Locations: 1 country
• Sites: 1

Brief Summary

An observational double-blind cohort study that examined the association between HCV viral hepatitis, blood sugar level and systolic blood pressure in the Egyptian population

Conditions

Hepatitis C, Acute; Diabetes; Hypertension

Outcome Measures

Primary Outcomes (3)

• HCV diagnosis

  Detection of patients who are HCV positive or negative

  20 minutes

• Measurement of blood sugar level in mg/dl

  Detection of the percentage of patients with high blood sugar level in HCV positive or negative patients

  1 minute

• Measurement of systolic blood pressure in mmHg

  Detection of the percentage of patients with high systolic blood pressure in HCV positive or negative patients

  1 minute

Study Arms (2)

HCV positive patients

Patients tested positive for the hepatitis c virus antibodies by BIOLINE HCV kits.

Diagnostic Test: BIOLINE HCV kits; Diagnostic Test: ACCU-CHEK kits; Diagnostic Test: ErKameter 3000 mercury manometer

HCV negative patients

Patients tested negative for the hepatitis c virus antibodies by BIOLINE HCV kits.

Diagnostic Test: BIOLINE HCV kits; Diagnostic Test: ACCU-CHEK kits; Diagnostic Test: ErKameter 3000 mercury manometer

Interventions

BIOLINE HCV kits DIAGNOSTIC_TEST

We used BIOLINE HCV kits to detect the presence of HCV antibodies in stick blood samples of all recruited patients.

Also known as: diagnosis of viral hepatitis C

HCV negative patients; HCV positive patients

ACCU-CHEK kits DIAGNOSTIC_TEST

For all patients, we measured random blood sugar levels by stick blood samples using ACCU-CHEK kits.

Also known as: measurement of blood sugar level

HCV negative patients; HCV positive patients

ErKameter 3000 mercury manometer DIAGNOSTIC_TEST

For all patients, we measured systolic blood pressure using ErKameter 3000 mercury manometer.

Also known as: blood pressure measurement

HCV negative patients; HCV positive patients

Eligibility Criteria

• Age: 18 Years - 80 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Egyptian patients aged 18-80 years.

You may qualify if:

• Egyptian citizens from 18 years to 80 years.

You may not qualify if:

• Patients younger than 18 years or older than 80 years

Sponsors & Collaborators

• Cairo University: lead

Study Sites (1)

Egyptian Ministry of Health

Asyut, 01234567, Egypt

Location

MeSH Terms

Conditions

Hepatitis C; Diabetes Mellitus; Hypertension

Interventions

Blood Pressure Determination

Condition Hierarchy (Ancestors)

Blood-Borne Infections; Communicable Diseases; Infections; Hepatitis, Viral, Human; Virus Diseases; Flaviviridae Infections; RNA Virus Infections; Hepatitis; Liver Diseases; Digestive System Diseases; Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases; Vascular Diseases; Cardiovascular Diseases

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, Cardiovascular; Diagnostic Techniques and Procedures; Diagnosis; Physical Examination

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: February 9, 2019
• First Posted: February 15, 2019
• Study Start: October 1, 2018
• Primary Completion: December 31, 2018
• Study Completion: January 31, 2019
• Last Updated: March 18, 2021

Record last verified: 2021-03

Data Sharing

• IPD Sharing: Will not share

Locations

EG (1)